selinexor has been researched along with Uterine-Cervical-Neoplasms* in 1 studies
1 other study(ies) available for selinexor and Uterine-Cervical-Neoplasms
Article | Year |
---|---|
Interference with XPO1 Suppresses the Stemness and Radioresistance of CD44 Positive Cervical Cancer Cells via Binding with Rad21.
Cancer stem cells (CSCs) are responsible for cervical cancer progression and decreased radiosensitivity of tumor cells. The present work is meant to illuminate the impacts of exportin 1 (XPO1) on the aggressive behaviors and radiosensitivity of cervical cancer stemness cells and make a deeper inquiry into its regulatory mechanism despite that XPO1 has been supported to elicit significant activities on multiple malignancies.. XPO1 and Rad21 expression in HeLa (CD44. The experimental data corroborated that XPO1 and Rad21 were overexpressed in cervical cancer tissues and cells. XPO1 inhibitor KPT-330 impeded the stemness while elevated the radiosensitivity of HeLa (CD44. To sum up, XPO1 might impact the aggressive behavior and radioresistance of cervical cancer stemness cells through binding with Rad21. Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Exportin 1 Protein; Female; Humans; Hyaluronan Receptors; Karyopherins; Uterine Cervical Neoplasms | 2023 |